Opexa Therapeutics, Inc. (OPXA) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Form 8-K Opexa Therapeutics, Inc. For: Aug 14
August 14, 2014 4:24 PM EDThttp://archive.fast-edgar.com/20140814/ABZ2222CZ222N9Z2222H2ZZ8BCESEO27X262 Filed on: August 14, 2014... More
Form 10-Q Opexa Therapeutics, Inc. For: Jun 30
August 14, 2014 4:07 PM EDThttp://archive.fast-edgar.com/20140814/A3Z2A22CZ22289Z2222S2ZZ8VPST4O27X262 Filed on: August 14, 2014... More
